SPIEGELMAN DANIEL K
SEC insider (Form 3/4/5 filer). CIK 0001238403. Director at vTv Therapeutics Inc. (VTVT) and 3 other issuers. 13 reported Form 4/5 transactions since Sep 2024; latest on Jun 26, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies SPIEGELMAN DANIEL K has filed insider reports for
- vTv Therapeutics Inc. (VTVT): Director
- Maze Therapeutics, Inc. (MAZE): Director
- SPRUCE BIOSCIENCES, INC. (SPRB): Director
- Kyverna Therapeutics, Inc. (KYTX): Director
SPIEGELMAN DANIEL K
CIK: 0001238403
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 26, 2026VTVT
vTv Therapeutics Inc.
AwardDirectDirector stock option (right to buy)
6K shares at avg. $35.08- - Jun 8, 2026MAZE
Maze Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
18K shares- - May 21, 2026SPRB
SPRUCE BIOSCIENCES, INC.
AwardDirectStock Option (Right to Buy)
1.7K shares- - Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
AwardDirectStock Option (Right to Buy)
400 shares- - Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
DispositionDirectStock Option (Right to Buy)
400 shares- - Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
DispositionDirectStock Option (right to buy)
88 shares- - Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
AwardDirectStock Option (Right to Buy)
458 shares- - Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
DispositionDirectStock Option (Right to Buy)
458 shares- - Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
AwardDirectStock Option (right to buy)
88 shares- - Sep 22, 2025MAZE
Maze Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
18K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 26, 2026 |  VTVT vTv Therapeutics Inc. | Award Director stock option (right to buy) | 6,000 | $35.08 | - | Direct |
| Jun 8, 2026 |  MAZE Maze Therapeutics, Inc. | Award Stock Option (Right to Buy) | 18,000 | - | - | Direct |
| May 21, 2026 |  SPRB SPRUCE BIOSCIENCES, INC. | Award Stock Option (Right to Buy) | 1,700 | - | - | Direct |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | Award Stock Option (Right to Buy) | 400 | - | - | Direct |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | Disposition Stock Option (Right to Buy) | 400 | - | - | Direct |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | Disposition Stock Option (right to buy) | 88 | - | - | Direct |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | Award Stock Option (Right to Buy) | 458 | - | - | Direct |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | Disposition Stock Option (Right to Buy) | 458 | - | - | Direct |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | Award Stock Option (right to buy) | 88 | - | - | Direct |
| Sep 22, 2025 | MAZE Maze Therapeutics, Inc. | Award Stock Option (Right to Buy) | 18,000 | - | - | Direct |
1-10 of 13 transactions